Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,980.00
-55.00 (-1.36%)
At close: Jul 25, 2025, 3:30 PM KST
-1.36%
Market Cap110.16B
Revenue (ttm)108.14B
Net Income (ttm)1.41B
Shares Out27.68M
EPS (ttm)60.34
PE Ratio65.96
Forward PEn/a
Dividend30.00 (0.74%)
Ex-Dividend DateMar 4, 2025
Volume2,044,285
Average Volume4,085,313
Open4,020.00
Previous Close4,035.00
Day's Range3,960.00 - 4,180.00
52-Week Range2,995.00 - 6,620.00
Beta0.48
RSI58.31
Earnings Daten/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive sy... [Read more]

Sector Healthcare
Founded 1965
Employees 393
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.